Search results
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's ...
The Herald Journal· 13 hours agoCEO David J. Bearss, Ph.D., will be participating in a panel discussing the "Landscape of Drug Discovery and Impact of AI Discussion" on Wednesday, May 22, from 1:50 to 2:30
Alzheimer’s biomarkers observed in young people with diabetes
MedicalNewsToday via AOL· 9 hours agoNew research shows that adolescents and young adults with type 1 or type 2 diabetes may be at higher...
Widespread, Long-Held Practice in Dementia Questioned
Medscape· 20 hours agoHospitalized patients with dementia and dysphagia are often prescribed a "dysphagia diet," made up...
How Does Alzheimer’s Kill?
MedicineNet.com· 4 days agoAlzheimer's disease (AD) is a degenerative disease of the brain, resulting in memory loss, cognitive decline, and personality changes ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 54 minutes agoEisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer'< ...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 5 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE ...
LIVING WELL: New drug approved to treat Alzheimer’s Disease
FOX 16 Little Rock· 23 hours agoThe FDA approved a new drug to treat Alzheimer’s Disease.
Nutrition and Alzheimer's disease may be linked, study finds
The Salem News· 3 days agoMalnutrition may increase a person’s chances of contracting Alzheimer’s disease, which in turn...
'Judge Judy' suing National Enquirer owner over Menéndez brothers article
Indianapolis Star via Yahoo News· 6 hours agoNational Enquirer published that Judy Judy had Alzheimer's disease Sheindlin, who hosted the...
Eisai starts rolling submission for injectable version of Alzheimer’s drug with US FDA
WHTC 1450 Holland· 2 hours ago(Reuters) - Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous ...